Medicine
Diacomit 250 mg powder for oral suspension
Diacomit 250 mg powder for oral suspension is a prescription medicine containing Stiripentol for oral use, marketed by Biocodex, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in a dry place at 20°C to 25°C (68°F to 77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Stiripentol
- Brand
- Diacomit
- Strength
- 250 mg
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 60 packets
- Marketing authorisation holder
- Biocodex
- Manufacturer
- Biocodex
- Origin register
- US FDA, United States
- Storage
- Store in a dry place at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Store in original package to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AX17 Stiripentol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 August 2018
- Identifiers
- RxCUI 2054973, 2054979, 2054981 +5DailyMed set ID 58304ba8-9779-4658-811e-94ffe08c3f16NDC 68418-7941Application NDA207223
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 packet in 1 carton / 1 powder, for suspension in 1 packet | 68418-7941-6 | Biocodex | 21 August 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Stiripentol
Clinical summary
Stiripentol is a prescription medicine indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more. MedsAcross supplies Stiripentol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about StiripentolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Diacomit prescribing information (Biocodex) · U.S. National Library of Medicine, DailyMed
- Diacomit: European public assessment report (EPAR) · European Medicines Agency
Need Diacomit 250 mg powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.